| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |